InvestorsObserver
×
News Home

Yumanity Therapeutics Inc (YMTX) Stock Is Down -21.70% This Week: Buy, Hold, or Sell?

Thursday, December 15, 2022 11:27 AM | InvestorsObserver Analysts

Mentioned in this article

Yumanity Therapeutics Inc (YMTX) Stock Is Down -21.70% This Week: Buy, Hold, or Sell?

Yumanity Therapeutics Inc (YMTX) stock is lower by -46.28% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives YMTX stock a score of 26 out of a possible 100.

That rank is chiefly influenced by a short-term technical score of 8. YMTX's rank also includes a long-term technical score of 70.
Overall Score - 26
YMTX has an Overall Score of 26. Find out what this means to you and get the rest of the rankings on YMTX!

What's Happening with YMTX Stock Today

Yumanity Therapeutics Inc (YMTX) stock is lower by -1.35% while the S&P 500 is lower by -2.48% as of 11:15 AM on Thursday, Dec 15. YMTX is lower by -$0.02 from the previous closing price of $1.68 on volume of 347,631 shares. Over the past year the S&P 500 is down -17.28% while YMTX is lower by -46.28%. YMTX lost -$3.00 per share in the over the last 12 months. Click Here to get the full Stock Report for Yumanity Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App